NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/ag ...

NEW YORK, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of agilon health, inc. (NYSE: AGL)? Did you purchase your shares between February 26, 2025 and August 4, 2025, inclusive? Did you lose money in your investment in agilon health, inc.? Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL) investors of an upcoming deadline involving a securi ...

LOS ANGELES, Jan. 21, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to agilon health, inc. ("agilon" or the "Company") (NYSE: AGL) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AGILON HEALTH, INC. (AGL), CLICK HERE BEFORE MARCH 2, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.  What Is The Lawsuit About? The complaint filed alleges that, betwee ...

Core Viewpoint - A class action lawsuit has been filed against Agilon Health, Inc. for allegedly making false and misleading statements regarding its financial guidance and business operations during the Class Period from February 26, 2025, to August 4, 2025 [3][7]. Allegation Details - The lawsuit claims that Agilon's defendants issued guidance for 2025 that they knew or should have known was unattainable due to significant industry challenges [3]. - It is alleged that the defendants overstated the immediate financial benefits from strategic actions taken to mitigate risks [3]. - As a result, the statements made about Agilon's business, operations, and future prospects were materially false and misleading throughout the Class Period [3]. Next Steps - Investors who purchased Agilon shares and experienced losses are encouraged to contact the law firm for more information regarding their rights and potential claims [4][7]. - The deadline for investors to apply to be appointed as lead plaintiff in the lawsuit is March 2, 2026 [7].

NEW YORK, Jan. 21, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in agilon health, inc. ("agilon health, inc." or the "Company") (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health, inc. investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/agilo ...

NEW YORK, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased agilon health, inc. (“agilon” or the “Company”) (NYSE:AGL) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your agilon investments, you have until March 2, 2026 to request lead plaintiff appointment. Courts do ...

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices i ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Agilon Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1] Group 1: Class Action Details - The Class Period for the securities class action is from February 26, 2025, to August 4, 2025 [1] - Investors who purchased Agilon securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 2, 2026 [3] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4] Group 3: Case Allegations - The lawsuit alleges that defendants made false or misleading statements and failed to disclose critical information, including issuing unrealistic guidance for 2025 despite known industry challenges [5] - It is claimed that defendants overstated the financial impact of strategic actions taken by Agilon, leading to materially false statements about the company's business and prospects [5] - The lawsuit asserts that when the true information became public, investors suffered damages [5]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities between February 26, 2025, and August 4, 2025, of the March 2, 2026, deadline to become a lead plaintiff in a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased agilon securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by March 2, 2026, to serve as lead plaintiff, representing other class members [3]. - The lawsuit alleges that defendants made false and misleading statements regarding agilon's financial guidance and the impact of strategic actions taken to reduce risk, which led to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting that many firms issuing notices may lack relevant experience [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to alleged violations of federal securities laws, particularly concerning misleading statements and guidance regarding the company's financial performance [2][5]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses in agilon health to contact them directly to discuss their legal options [1]. - A federal securities class action has been filed against agilon health, with a deadline of March 2, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that agilon health and its executives made false statements and failed to disclose significant industry challenges, leading to misleading guidance for 2025 [5]. Group 2: Financial Impact and Stock Performance - On August 4, 2025, agilon health announced the suspension of its previously issued full-year 2025 financial guidance, citing more acute industry headwinds than expected [6]. - Following this announcement, agilon health's stock experienced a significant decline of 51.5% on August 5, 2025 [6]. Group 3: Company Background - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its establishment in 1995 [4].